-
Congress Dinner
Done
-
Flash Session I (B)
Clara B. MartinsDone
-
Oral Session II C
Gabriela MartinsDone
-
Oral Session III A
Mariana FiadeiroDone
-
Coffee and Pastel de Nata @Nata Lisboa Covilhã and City Center Walk
Done
-
Oral Session I C
Diana GomesDone
-
Hot Topics I: Proteins vs. Nucleic Acids as Diagnostic tool
Joana Guerreiro (PhD) and Professor Rúben Fernandes (PhD)/Cláudia Pereira (PhD)Done
-
Flash Session I (C)
Rafaella CoelhoDone
-
Oral Session IV A
Nádia OliveiraDone
-
Plenary Session III
Giovanni Viegi, M.D.; Ph.D.Done
Enterprise Plenary Session III
15/02/2023, 09:40
-
15/02/2023, 10:40
(UTC)
(1 hour)
GenIbet Biopharmaceuticals is a company whose mission is to manufacture safe and reliable breakthrough products to support worldwide customers on building the therapies of the future. With a team of more than 50 highly qualified professionals, GenIbet supports its customers on the development and manufacturing of unique novel modalities covering a wide range of technologies.
Sofia Venceslau obtained her Ph.D. degree from the NOVA University of Lisbon, Institute of Chemical and Biological Technology (Oeiras, Portugal) in 2011 and is currently a Project Manager in GenIbet Biopharmaceuticals and will be the third confirmed enterprise speaker for the HSR Congress 2023 on February 15th, 2023.
